venerdì, 9 giugno 2023
25 Novembre 2016

CAP/ASCP/ASCO Guideline on HER2 Testing and Clinical Decision-Making in Gastroesophageal Adenocarcinoma

As reported by Angela N. Bartley, MD, of St Joseph Mercy Hospital, Ann Arbor, and colleagues in the Journal of Clinical Oncology, the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), and ASCO have released a guideline on HER2 testing and clinical decision-making in gastroesophageal adenocarcinoma. The guideline was developed by an expert panel, consisting of practicing pathologists, oncologists, and a gastroenterologist … (leggi tutto)